Solvay Pharmaceuticals, Inc. Q4 Operating Profit Down 53%, Below Forecast

BRUSSELS, Feb 19 (Reuters) - Belgium’s Solvay missed forecasts with a 53 percent fall in fourth-quarter operating profit on plunging plastics demand and said it had prepared for a difficult next two years.

MORE ON THIS TOPIC